These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4274938)

  • 1. Some aspects of fibrinogen biochemistry: interaction with proteolytic enzymes.
    Donati MB
    Acta Vitaminol Enzymol; 1973; 27(5):233-41. PubMed ID: 4274938
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of bile salts on some coagulation components and related enzymes.
    Engel AM; Alexander B
    Thromb Diath Haemorrh; 1972 Jul; 27(3):594-609. PubMed ID: 4268053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Structure of fibrinogen in view of the properties and structure of proteolytic products of degradation by plasmin].
    Budzyński AZ
    Postepy Hig Med Dosw; 1969; 23(3):293-369. PubMed ID: 4240986
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modern concepts of the hemostatic and fibrinolytic systems].
    Andreenko GV
    Klin Med (Mosk); 1974 Apr; 52(4):13-23. PubMed ID: 4282102
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen and dysfibrinogenemia.
    Morse EE
    Ann Clin Lab Sci; 1980; 10(4):351-5. PubMed ID: 7447388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tests for the diagnosis of consumption coagulopathy.
    Niewiarowski S
    Thromb Diath Haemorrh Suppl; 1969; 36():277-9. PubMed ID: 4246464
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinogen and the fibrinogenopathies.
    Morse EE
    Ann Clin Lab Sci (1971); 1971; 1(2):155-61. PubMed ID: 4949447
    [No Abstract]   [Full Text] [Related]  

  • 10. Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
    Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1973; 56():91-112. PubMed ID: 4281941
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic defibrination--a new principle of anticoagulant therapy].
    Voss D
    Internist (Berl); 1968 Sep; 9(9):389-90. PubMed ID: 4918659
    [No Abstract]   [Full Text] [Related]  

  • 12. Degradation of fibrinogen by proteolytic enzymes. I. Characterization and isolation of products and their relation to fibrinolytic states.
    Sanchez-Avalos J; Miller SP
    Thromb Diath Haemorrh; 1968 Jul; 19(3):499-515. PubMed ID: 4974324
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathological fibrinolysis.
    Fletcher AP
    Fed Proc; 1966; 25(1):84-8. PubMed ID: 4283650
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of tannin for the examination of the digestive process of casein and fibrinogen by plasmin and for the preparation of the polypeptide end products of proteolysis].
    Mejbaum-Katzenellenbogen ; Kolaczkowska M
    Acta Physiol Pol; 1970; 21(2):235-42. PubMed ID: 4248418
    [No Abstract]   [Full Text] [Related]  

  • 15. [The critical role of the interaction of anion-binding thrombin exosite with complementary segment of the Aalpha-chain of fibrinogen in detecting high specificity of the enzyme].
    Sereĭskaia AA; Smirnova IV; Karabut LV; Chetyrkina SN
    Biokhimiia; 1994 Mar; 59(3):360-7. PubMed ID: 8180269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for localization of polymerization sites in fibrinogen.
    Kudryk BJ; Collen D; Woods KR; Blombäck B
    J Biol Chem; 1974 May; 249(10):3322-5. PubMed ID: 4275342
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of the fibrinolytic enzyme system in laboratory animals and in man. A comparative study.
    Baillie AJ; Sim AK
    Thromb Diath Haemorrh; 1971 Jun; 25(3):499-506. PubMed ID: 4254504
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E
    Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemia.
    Lassman HB; Wilkens HJ; Back N
    J Pharmacol Exp Ther; 1974 May; 189(2):317-26. PubMed ID: 4275231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.